GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » Days Sales Outstanding

Sinocelltech Group (SHSE:688520) Days Sales Outstanding : 126.86 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group Days Sales Outstanding?

Sinocelltech Group's average Accounts Receivable for the three months ended in Mar. 2025 was ¥723 Mil. Sinocelltech Group's Revenue for the three months ended in Mar. 2025 was ¥520 Mil. Hence, Sinocelltech Group's Days Sales Outstanding for the three months ended in Mar. 2025 was 126.86.

The historical rank and industry rank for Sinocelltech Group's Days Sales Outstanding or its related term are showing as below:

SHSE:688520' s Days Sales Outstanding Range Over the Past 10 Years
Min: 61.21   Med: 127.68   Max: 1233.22
Current: 87.45

During the past 9 years, Sinocelltech Group's highest Days Sales Outstanding was 1233.22. The lowest was 61.21. And the median was 127.68.

SHSE:688520's Days Sales Outstanding is ranked worse than
61.84% of 849 companies
in the Biotechnology industry
Industry Median: 70.29 vs SHSE:688520: 87.45

Sinocelltech Group's Days Sales Outstanding increased from Mar. 2024 (56.24) to Mar. 2025 (126.86).


Sinocelltech Group Days Sales Outstanding Historical Data

The historical data trend for Sinocelltech Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group Days Sales Outstanding Chart

Sinocelltech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only - 221.60 61.26 61.21 74.12

Sinocelltech Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.24 59.33 77.22 95.35 126.86

Competitive Comparison of Sinocelltech Group's Days Sales Outstanding

For the Biotechnology subindustry, Sinocelltech Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinocelltech Group's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinocelltech Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sinocelltech Group's Days Sales Outstanding falls into.


;
;

Sinocelltech Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sinocelltech Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (371.164 + 649.386) / 2 ) / 2512.708*365
=510.275 / 2512.708*365
=74.12

Sinocelltech Group's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (649.386 + 795.717) / 2 ) / 519.737*365 / 4
=722.5515 / 519.737*365 / 4
=126.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocelltech Group  (SHSE:688520) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Sinocelltech Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocelltech Group Business Description

Traded in Other Exchanges
N/A
Address
Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.
Executives
Xie Liang Zhi Director

Sinocelltech Group Headlines

No Headlines